Document is current
Any future updates will be listed below
-
Authors
Mastrangelo, Annalaura https://orcid.org/0000-0003-2650-0444
Robles-Vera, Iñaki https://orcid.org/0000-0001-6002-9241
Mañanes, Diego https://orcid.org/0000-0001-7247-6794
Galán, Miguel https://orcid.org/0000-0002-6695-1509
Femenía-Muiña, Marcos
Redondo-Urzainqui, Ana
Barrero-Rodríguez, Rafael
Papaioannou, Eleftheria
Amores-Iniesta, Joaquín
Devesa, Ana https://orcid.org/0000-0001-5981-2546
Lobo-González, Manuel
Carreras, Alba
Beck, Katharina R.
Ivarsson, Sophie https://orcid.org/0009-0009-4050-9075
Gummesson, Anders
Georgiopoulos, Georgios
Rodrigo-Tapias, Manuel
Martínez-Cano, Sarai
Fernández-López, Ivan
Nuñez, Vanessa
Ferrarini, Alessia https://orcid.org/0000-0002-4587-6095
Inohara, Naohiro
Stamatelopoulos, Kimon
Benguría, Alberto https://orcid.org/0000-0002-5536-566X
Cibrian, Danay
Sánchez-Madrid, Francisco
Alonso-Herranz, Vanesa
Dopazo, Ana https://orcid.org/0000-0002-4910-1684
Barbas, Coral https://orcid.org/0000-0003-4722-491X
Vázquez, Jesús https://orcid.org/0000-0003-1461-5092
López, Juan Antonio https://orcid.org/0000-0002-9097-6060
González-Martín, Alicia
Nuñez, Gabriel
Stellos, Konstantinos https://orcid.org/0000-0002-0194-0825
Bergström, Göran https://orcid.org/0000-0003-4289-5722
Bäckhed, Fredrik
Fuster, Valentín
Ibañez, Borja https://orcid.org/0000-0002-5036-254X
Sancho, David https://orcid.org/0000-0003-2890-3984
- License Information
-
More Information
Article History
Received: 1 June 2023
Accepted: 9 June 2025
First Online: 16 July 2025
Competing interests
: F.B. receives research funding from Biogaia AB and Novo Nordisk A/S, is co-founder and shareholder of Roxbiosens Inc., and is on the scientific advisory board of Bactolife A/S. F.B., K.R.B. and A.C. are co-founders and shareholders of Implexion Pharma AB. A.M., I.R.-V., D.S., B.I., V.F. and D.M. are inventors on a patent application titled Antagonists of the I1R for use in the Prevention and/or Treatment of an Autoinflammatory or Autoimmune Disease, publication number WO2025002914 (2025). The other authors declare no competing interests.
